Advances in the Physicochemical Profiling of Opioid Compounds of Therapeutic Interest
Open accessThe DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index.
Abstract
This review focuses on recent developments in the physicochemical profiling of morphine and other opioids. The acid‐base properties and lipophilicity of these compounds is discussed at the microscopic, species‐specific level. Examples are provided where this type of information can reveal the mechanism of pharmacokinetic processes at the submolecular level. The role of lipophilicity in quantitative structure–activity relationship (QSAR) studies of opioids is reviewed. The physicochemical properties and pharmacology of the main metabolites of morphine are also discussed. Recent studies indicate that the active metabolite morphine‐6‐glucuronide (M6G) can contribute to the analgesic activity of systemically administered morphine. The unexpectedly high lipophilicity of M6G partly accounts for its analgesic activity. When administered parenterally, another suspected minor metabolite, morphine‐6‐sulfate (M6S) has superior antinociceptive effects to those of morphine. However, because sulfate esters of morphine derivatives cannot cross the blood‐brain barrier these esters may be good candidates to develop peripheral analgesic drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry
Beale, J. M., & Block, J. H. (2011) · Andalas University Repository (Andalas University) · Cited by 914
Abraham, M. H., Chadha, H. S., Whiting, G. S., & Mitchell, R. C. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830806 · Cited by 766
van de Waterbeemd, H., Camenisch, G., Folkers, G., Chretien, J. R., & Raevsky, O. A. (1998) · Journal of Drug Targeting · doi:10.3109/10611869808997889 · Cited by 587
Clinical Pharmacology of Opioids for Pain
Inturrisi, C. E. (2002) · The Clinical Journal of Pain · doi:10.1097/00002508-200207001-00002 · Cited by 571
CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure
Rankovic, Z. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501535r · Cited by 548
Wager, T. T., Chandrasekaran, R. Y., Hou, X., Troutman, M. D., Verhoest, P. R., Villalobos, A., & Will, Y. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100007x · Cited by 477
Absorption and Drug Development: Solubility, Permeability, and Charge State
Avdeef, A. (2012) · Wiley eBooks · doi:10.1002/9781118286067 · Cited by 446
Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite.
Paul, D., Standifer, K. M., Inturrisi, C. E., & Pasternak, G. W. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20832-1 · Cited by 393
Lipid solubility and drug penetration of the blood brain barrier
Oldendorf, W. H. (1974) · Experimental Biology and Medicine · doi:10.3181/00379727-147-38444 · Cited by 373
The significance of acid/base properties in drug discovery
Manallack, D. T., Prankerd, R. J., Yuriev, E., Oprea, T. I., & Chalmers, D. K. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35348b · Cited by 329
Research works printed but not linked: 5
- 14. T. L. Yaksh, M. S. Wallace, Goodman & Gilman's The Pharmaceutical Basis of Therapeutics (Eds.: L. L. Brunton, B. A. Chabner, B. C. Knollmann), McGraw-Hill Medical 2010, pp. 481-527.
- 23. A. E. Jacobson, W. A. Klee, W. J. Dunn, Eur. J. Med. Chem. 1977, 12, 49- 52.
- 24. A. E. Jacobson, NIDA Res. Monogr. 1978, 22, 129-45.
- 48. D. Wu, Y. S. Kang, U. Bickel, W. M. Pardridge, Drug Metab. Dispos. 1997, 25, 768-771.
- 60. J. Lötsch, G. Geisslinger, Clin. Pharmacokinet. 2001, 40, 485-499.
Cited by
Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic
Balyan, R., Hahn, D., Huang, H. D., & Chidambaran, V. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1721458 · Cited by 31
“[30] and will not be presented further here).”
BackgroundOpioids and pituitary function: expert opinion
Gadelha, M. R., Karavitaki, N., Fudin, J., Bettinger, J. J., Raff, H., & Ben-Shlomo, A. (2022) · Pituitary · doi:10.1007/s11102-021-01202-y · Cited by 27
Shaabani, N., Chan, N. W. C., Lee, W. E., & Jemere, A. B. (2020) · Journal of The Electrochemical Society · doi:10.1149/1945-7111/abbb0d · Cited by 27
Physicochemical Properties of Zwitterionic Drugs in Therapy
Mazák, K., & Noszál, B. (2020) · ChemMedChem · doi:10.1002/cmdc.202000164 · Cited by 23
Self-citationA Molecularly Imprinted Sol-Gel Electrochemical Sensor for Naloxone Determination
Shaabani, N., Chan, N. W. C., & Jemere, A. B. (2021) · Nanomaterials · doi:10.3390/nano11030631 · Cited by 23
“55 and it exists in four tautomeric forms in solution [51].”
BackgroundFernandes, A. M., Campos, J., Silva, D., Barata‐Antunes, S., Lima, R., Coelho, C., Marote, A., Leite‐Almeida, H., Silva, N. A., & Salgado, A. J. (2022) · Stem Cells and Development · doi:10.1089/scd.2022.0116 · Cited by 17
“At high doses, buprenorphine will interact to KOR to exhibit the analgesic effect [49,50].”
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14
Evaluation of Injectable Naloxone-Releasing Hydrogels
Crowe, K. M., Siddiqui, Z., Harbour, V., Kim, K., Syed, S., Paul, R., Roy, A., Naik, R., Mitchell, K., Mahajan, A., et al. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01016 · Cited by 13
Synthesis of Potential Haptens with Morphine Skeleton and Determination of Protonation Constants
Köteles, I., Mazák, K., Tóth, G., Tűz, B., & Hosztafi, S. (2020) · Molecules · doi:10.3390/molecules25174009 · Cited by 10
“The water signal was suppressed by presaturation [44].”
BackgroundSelf-citationAkhgari, M., Iravani, F. S., & Ghadipasha, M. (2021) · PubMed Central · doi:10.22122/ahj.v13i1.296 · Cited by 13
Tűz, B., Noszál, B., Hosztafi, S., & Mazák, K. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106120 · Cited by 7
Self-citationKlose, M., Cristofoletti, R., Silva, C. D. M., Mangal, N., Turgeon, J., Michaud, V., Lesko, L. J., & Schmidt, S. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106689 · Cited by 6
Köteles, I., Mazák, K., Tóth, G., Horváth, P., Kiss, E., Tűz, B., & Hosztafi, S. (2021) · Chemistry & Biodiversity · doi:10.1002/cbdv.202100135 · Cited by 6
“[22] The ionization state of a molecule in solution is determined by its acid-base character and the pH of the solution.”
BackgroundSelf-citationCharacterization of Opioid Agonist Morphine Derivatives with Emphasis on Medicinal Chemistry
Malik, A., Hosztafi, S., Vincze, A., Marton, A., Kraszni, M., Balogh, G. T., Noszál, B., & Mazák, K. (2024) · ChemMedChem · doi:10.1002/cmdc.202400654 · Cited by 6
Self-citationVerma, A., Ogunsola, S. S., Keith, K. A., & Jayawardana, G. D. T. L. (2025) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2025.104880 · Cited by 4
Distribution of morphine and methadone to the brain in a developmental chicken embryo model
Rajalingam, D., Boix, F., Khoder, A., Andersen, J. M., & Paulsen, R. E. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116731 · Cited by 5
MOHAMMAD, A. E., Muhammad-Ali, M. A., & Jasim, E. Q. (2022) · PERIÓDICO TCHÊ QUÍMICA · doi:10.52571/ptq.v19.n42.2022.02_munther_pgs_12_28.pdf · Cited by 3
Simon, B., Köteles, I., Kovács, R., Kraszni, M., Horváth, P., Hosztafi, S., & Mazák, K. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107089 · Cited by 3
Self-citationHnin, H. M., Tun, T., Nalinratana, N., & Jansook, P. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107277 · Cited by 4
Comparison of Orthogonal Determination Methods of Acid/Base Constants with Meta-Analysis
Pálla, T., Mazák, K., Alkhazragee, D. M., Balogh, G. T., Noszál, B., & Mirzahosseini, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312727 · Cited by 2
Self-citationKoushik, S. S., Gritsenko, K., Binda, D. D., Daybell, I. S., Hill, N. S., Raghavan, J., Borukh, E., Smith, B. B., Kraus, M. B., & Shaparin, N. (2026) · CNS Drugs · doi:10.1007/s40263-026-01320-w · Cited by 1
“%) may limit peak analgesic effect but does not eliminate opioid-related risks, as a substantial portion of the dose may still be absorbed via gastrointestinal swallowing [42–45].”
Regulatory and Safety Aspects of Ink Formulation and Use
Thompson, M., & Woods, J. (2022) · Wiley eBooks · doi:10.1002/9783527828074.ch72
Yahyazadeh, M., Rahimifard, M., Hadi, N., Shirazi, Z., صنم, س. ا., Azimi, R., Ajani, Y., Makizadeh, M., Moradi, A., Bidarlord, M., et al. (2024) · Angewandte Botanik · doi:10.5073/jabfq.2024.097.011
3D printed mucoadhesive gastric patch provides long-acting naltrexone delivery
Bollareddy, S. R., Vatsavai, N., & Venuganti, V. V. K. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126570
Application of squalenoylation in chronic pain alleviation
Silva, A. D. (2023) · theses.fr (ABES) · doi:10.70675/83a7bd41z85b4z4dcazaa47z92efc29ff8da
Malik, A., Hosztafi, S., Noszál, B., Balogh, G. T., & Mazák, K. (2026) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2026.107539
Self-citationAydın, S., Ulvi, A., & Aydın, M. E. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.128363
Saphier, S., Wenger, A., Pevzner, A., Yeffet, D., Smolkin, B., Karton-Lifshin, N., Elias, S., Eichen, Y., Parvari, G., Katalan, S., et al. (2026) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6c00324
Isokinoliinialkaloidien potentiaali antibakteeriaalisina aineina
Tuorila, N. (2026) · UTUPub (University of Turku)
Metadata
- Authors
- Mazák, K., Noszál, B., & Hosztafi, S.
- Affiliations
- Semmelweis University (HU)
- Corresponding author
- Mazák, Károly
- Venue
- ChemistryOpen
- Publisher
- Wiley
- Published
- 2019-07
- Volume
- 8
- Issue
- 7
- Pages
- 879-887
- ISSN
- 2191-1363 (ISSN-L)
- PMC
- PMC6610444
- OpenAlex
- W2955693718
- Semantic Scholar
- 922c3a0bc3e9d60e0d7c75fff264b3098df2f0dd
- Cited by
- 27
- References
- 65
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 1
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- ChemistryOpen (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Fonds National de la Recherche Luxembourg
- Hungarian Scientific Research Fund (T 73804)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Keywords
- morphine, opioids, physicochemical profiling, lipophilicity, acid-base properties, pharmacokinetics, QSAR, morphine metabolites, morphine-6-glucuronide, analgesic activity, blood-brain barrier, peripheral analgesics, antinociception
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.